Partner With Us NRI

Apollo Hospitals Enterprise Ltd share Price

Company details

6M Return 16.74%
1Y Return 8.36%
Mkt Cap.(Cr) 71,742.24
Volume 348,459
Div Yield 0.30%
OI Chg %
Volume 348,459

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
Stable numbers amid seasonality impact...
About The Stock

    Apollo is one of the leading integrated healthcare service provider with avenues like hospitals, pharmacies, primary care & diagnostic clinics.

    • Group capacity of 10,033 beds across 71 hospitals in India. Total 8660 beds owned in 44 hospitals; 278 beds in 11 cradles; 244 beds in 11 day-care/short surgical stay centres; 851 beds in five hospitals under O&M contracts
    • It has got a digital presence with “ASK Apollo” & digital health platform “Apollo 24/7”. Apollo Hospitals is the exclusive supplier for APL, which operates India’s largest standalone pharmacy chain with 4,390 outlets
    • Apollo Health & Lifestyle Ltd runs the largest chain of standardised primary healthcare models, multi-specialty clinics under the brand: Apollo Clinics in India and Middle East, diabetes management clinics: Apollo Sugar, diagnostic centres: Apollo Diagnostics, specialty formats: Apollo Cradle for women & children, Apollo Spectra for planned surgery

    Apollo reported in-line results but skewed with Hospitals lagging our expectations but pharmacies a beat on our estimates.

    • Revenues increased 31.9% YoY to ₹ 3638.9 crore
    • EBITDA was at ₹ 587 crore, up 50.4% YoY with margins at 16.1%
    • Adjusted PAT was at ₹ 228.4 crore (up 75.1% YoY)

Click here for full recommendation

Research view on more stocks

Healthcare Facilities company Apollo Hospitals Enterprise announced Q4FY23 & FY23 results:

  • Q4FY23:
    • Revenues grew 21% to Rs 43,022 million vs Rs 35,464 million in Q4FY22
    • EBITDA excluding 24/7 Operating Cost and ESOP charge stood at Rs 706 million; 29% YoY growth
    • Apollo 24/7 cost of Rs 2,174 million in the quarter (including Rs 281 million non-cash ESOP charge) vs Rs 841 million in Q4FY22
    • EBITDA post 24/7 Operating Cost and ESOP charge at Rs 4,882 million vs Rs 4,632 million in Q4FY22; 5% YoY growth
    • PAT grew 60% to Rs 1,445 million vs Rs 901 million in Q4FY23
    • Diluted EPS of Rs 10.05 per share in Q4FY23 (not annualised)
  • FY23:
    • Revenues grew 13% to Rs 166,125 million vs Rs 146,626 million in FY22
    • EBITDA excluding 24/7 Operating Cost and ESOP charge stood at Rs 27,851 crore ;16% YoY growth
    • Apollo 24/7 cost of Rs 7,355 million for the full year (including Rs 781 million non-cash ESOP charge) vs Rs 2,236 million in FY22
    • EBITDA post 24/7 Operating Cost and ESOP charge at Rs 20,496 million vs Rs 21,851 million in FY22
    • PAT stood at Rs 8,191 million vs of Rs 10,556 million in FY22
    • Diluted EPS of Rs 56.97 per share in FY23

Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group said, “The first full post-pandemic year has seen Apollo make some remarkable strides in its journey of healing. Our unwavering commitment to deliver world-class healthcare has enabled us to scale new heights with our performance - both in terms of financial metrics and in the expansion of our healthcare service offerings. We have seen a substantial increase in patient engagement both in our hospitals and clinics, as well as on our digital health platform Apollo 24/7.

We have continued to broaden our services, ensuring that we focus not just on cure, but on preventive healthcare as well. At a time when the world is realizing the importance of prevention more than ever before, it is a matter of pride that Apollo has been at the forefront of this shift, recognizing that the best way to fight disease is to prevent it in the first place. One of our areas of focus is Artificial Intelligence (Al), which we believe holds the power to revolutionize preventive healthcare, by helping identify patterns, predict health risks, and enable early interventions. This year, we have invested thoughtfully in Al technologies, and the results have been heartening. They have allowed us to provide a personalized healthcare approach for every individual, taking into account their unique genetic disposition, lifestyle, and medical history."


Result PDF

View Other Company Results


Investment recommendation
Stable numbers amid seasonality impact...
Call Date
16 Feb 2023
Entry Price 4,487.00
Target Price 5,460.00
12-18 Month


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Apollo Hospitals Enterprise Ltd Stocks COMPARISION


Equity Capital: 6,197.40 Cr FV: 5.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 13,565.29 -8,591.81
LAST 3M 37,244.98 3,231.65
LAST 6M 45,909.21 154,115.29
LAST 12M 133,371.71 158,810.39

Apollo Hospitals Enterprise Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • Apollo Hospitals Enterprise Ltd works in the Healthcare sector is having a market capitalization worth Rs. 68,247.55 crores, it was incorporated in the year 1983. It has reported consolidated sales of Rs. 2,867.95 crores in March’2021. The company is listed on the Bombay Stock Exchange (BSE) with the code 508869, and also listed on the National Stock Exchange (NSE) with the code APOLLOHOSP.

    Apollo Hospitals Enterprise Ltd is an Indian international hospital chain having its headquarters in Chennai, Tamil Nadu. Many of the Apollo Hospitals' hospitals have been among the country's first to receive an international healthcare certification from the Joint Commission International (JCI) and the National Accreditation Board for Hospitals and Healthcare Service Providers. Apart from the Hospital business, Apollo has established a presence in Pharmacies, Primary Care, and Diagnostics. Apollo hospitals has a national presence through an established network of over 70 hospitals and 3800 pharmacies spread across the country. The promoters of the company own 29.82% of the stake in the company, Foreign Institutional Investors (FII) own 53.23%, Domestic Institutional Investors (DII) own 11.08% stake in the company, and others (such as public & retail investors) hold the balance of 5.87%.

    In June 2021, quarterly net revenue was Rs. 2,994.71 crores, which has increased sharply by approximately 52.67 % from Rs. 1,961.52 crores for the April-June 2020 quarter. The quarterly net profit in June 2021 was Rs. 150.04 crores, which has improved sharply and increased by nearly 200.62% from a net loss of Rs. 149.11 crores in June 2020. In June 2021, the reported operating profit was at Rs. 2,553.01 crores, which is also increased by 60.55% as compared to an operating profit of Rs. 1,590.2 crores for the quarter ending in June 2020. From a negative EPS of Rs. 10.72 in June 2020, the EPS of Apollo Hospitals Enterprises Ltd has improved and reached Rs. 10.44 per share in June 2021. APOLLOHOSP's stock closed at Rs. 4,746.50 on 20th August’2021 (NSE) and has given a return of 52.78% in the last six months and a return of 179.67% in the previous year.

Registered Address

No 19 Bishop Garden, Raja Annamalaipuram, Chennai, Tamil Nadu, 600028

Tel : 91-44-28290956/28293896
Email : apolloshares:vsnl.net
Website : http://www.apollohospitals.com

Integrated Registry Mgt Servic

AGM Date (Month) : Aug
Face Value Equity Shares : 5
Market Lot Equity Shares : 1
BSE Code : 508869
Book Closure Date (Month) :
BSE Group : A
ISIN : INE437A01024

FAQ’s on Apollo Hospitals Enterprise Ltd Shares

You can buy Apollo Hospitals Enterprise Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Apollo Hospitals Enterprise Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Sep 22, 2023 03:59 PM the closing price of Apollo Hospitals Enterprise Ltd was ₹ 4,989.55.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Sep 22, 2023 03:59 PM, the market cap of Apollo Hospitals Enterprise Ltd stood at ₹ 71,742.24.

The latest PE ratio of Apollo Hospitals Enterprise Ltd as of Sep 22, 2023 03:59 PM is 107.25

The latest PB ratio of Apollo Hospitals Enterprise Ltd as of Sep 22, 2023 03:59 PM is 0.09

The 52-week high of Apollo Hospitals Enterprise Ltd is ₹ 5,364.00 while the 52-week low is ₹ 4,123.00

According to analyst recommendations, Apollo Hospitals Enterprise Ltd has a “Buy” rating for the long term.

Download Our App

market app
market app